These cardiovascular features of WBS are mainly related to a gene-dosage effect due to hemizygosity of the elastin gene (ELN) which encodes the elastin protein; however, the phenotypic variability among WBS patients indicates the presence of important modulators of the clinical impact of elastin deficiency [1]. This evidence concerns the gene ELN and Williams syndrome.